MDG1 — Medigene AG Share News
0.000.00%
Last trade - 00:00- €2.51m
- -€8.97m
- €6.03m
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million
Brief: Medigene Presents Efficient 6-Day Tcr-T Therapy Production Process
Brief: Medigene Says Co Plans To Reduce Share Capital & Amends Financial Guidance For 2024
Brief: Medigene AG Launches Capital Increase With Subscription Rights And Backstop Agreement
Brief: Medigene FY Revenue EUR 6 Million
Brief: Medigene Announces Indication Selection For The Clinical Development Of Lead Therapy Program In Solid Tumors
Brief: Medigene AG Exploring Financing Options To Extend Cash Runway Into 2026 & Beyond
Brief: Medigene Announces Prioritization Of Pipeline & Resource Allocation, Extension Of Cash Runway
Brief: Medigene Says Maintains Its Guidance For Fiscal Year 2023
Brief: Medigene Sees FY revenue at EUR 5-7 Million
Brief: Medigene AG Announces Appointment Of Dr. Kirsty Crame, MD, As Head Of Clinical Research & Development
Brief: Medigene AG Says Amends 2022 Financial Guidance
Brief: Medigene Receives $3 Mln Milestone Payment From 2Seventy Bio
Brief: Medigene Says Sees 2022 Forecast For EBITDA From EUR 3 - 5 Mln To EUR 8 - 9 Mln
Brief: Medigene AG Says Selwyn Ho Appointed New CEO Of Medigene
Brief: Medigene Q1 EBITDA Turns To Profit At EUR 16.8 Mln